http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107519191-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107519191-B |
| titleOfInvention | Purposes of the glucoside compound in preparation treatment diabetes medicament |
| abstract | The invention discloses a kind of purposes of the compound shown in formula (I) in preparation prevention and/or treatment diabetes medicament.Test proves that the compound of the present invention is significantly reduced effect to blood glucose.Also, in middle high dose, moreover it is possible to reduce AUC and increase blood glucose inhibiting rate, while have no obvious toxic-side effects, drug is safe and effective, has broad application prospects. |
| priorityDate | 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.